Not a good buy right now: price is extended/overbought (RSI-6 ~81) and trading right at/just above near-term resistance (R1 ~15.781), which makes the immediate risk/reward unattractive for an impatient entry.
Trend is bullish (SMA_5 > SMA_20 > SMA_200, MACD expanding), but without a proprietary buy signal today, I would not chase strength at resistance.
Best stance now is HOLD/avoid new entry until either (1) a pullback toward the pivot (15.30) / support (14.81) or (2) a clean breakout and hold above ~16.08 (R2).
Trend: Bullish alignment (SMA_5 > SMA_20 > SMA_200) suggests an established uptrend.
Momentum: MACD histogram +0.0716 and expanding supports continued upward momentum.
Overbought: RSI_6 at ~80.98 flags short-term exhaustion risk (higher probability of a pullback/consolidation).
Levels: Pivot 15.297; Support S1 14.814 (then S2 14.516). Resistance R1 15.781 and R2 16.079.
Price context: Post-market ~15.8 sits around/above R1, increasing odds of near-term stalling unless it decisively clears and holds toward R2.
Pattern-stat model: Similar-pattern stats imply slight weakness next day/week (-0.28% / -0.56%) but modestly positive 1-month bias (+1.37%), aligning with “uptrend but extended short term.”
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Liquidity/signal quality is very thin: total call OI ~2, put OI 0, and today’s option volume 0—options market sentiment read-through is low confidence.
Volatility: 30D IV ~70.09 vs historical vol ~27.01 indicates options are priced rich (market implying big moves), which often happens in illiquid names or around uncertainty.
IV positioning: IV percentile ~71.71 suggests elevated IV relative to its own history; not an obvious “complacent” setup.
Net takeaway: options data does not provide a strong bullish confirmation; it mostly signals expensive implied vol with minimal participation.
Technical Summary
Sell
4
Buy
9
Positive Catalysts
Financial momentum: 2025/Q4 showed strong YoY growth in revenue, net income, and EPS (supports the broader bullish trend).
Technical trend remains constructive (bullish moving averages + positive MACD), so a breakout above ~16.08 could attract momentum buyers.
Flows: Hedge funds and insiders are reported Neutral (no negative flow overhang).
Neutral/Negative Catalysts
increases probability of a pullback or sideways digestion.
Net income: $5.647M, +15.24% YoY (profit growth, though slower than revenue).
EPS: $0.31, +19.23% YoY (good per-share growth).
Margin line provided shows “Gross Margin 0”; treat as data-quality/coverage limitation rather than an economic conclusion.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided, so a “Wall Street pros/cons” consensus trend cannot be confirmed from this dataset.
Practical read: absent published upgrades/target hikes here, the current setup must be judged primarily on technicals + fundamentals; technically it’s bullish but tactically overbought at resistance (not an attractive immediate buy).
Wall Street analysts forecast FVCB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FVCB is 16 USD with a low forecast of 16 USD and a high forecast of 16 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast FVCB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FVCB is 16 USD with a low forecast of 16 USD and a high forecast of 16 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 15.720
Low
16
Averages
16
High
16
Current: 15.720
Low
16
Averages
16
High
16
Piper Sandler
Overweight
initiated
$16
AI Analysis
2025-07-09
Reason
Piper Sandler
Price Target
$16
AI Analysis
2025-07-09
initiated
Overweight
Reason
Piper Sandler assumed coverage of FVCBankcorp with an Overweight rating and $16 price target. The firm sees an attractive valuation and improving profitability for the bank. FVCBankcorp has a geographically well positioned franchise and strong capital levels with a low-risk credit profile, the analyst tells investors in a research note.
